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Due to the growing knowledge about the role of specific fatty acids in health and disease, dietary intake measurements of individual fatty acids or
classes of fatty acids are becoming increasingly important. The objective of this study was to evaluate the ability of the Nambour FFQ to estimate
intakes of specific fatty acids, particularly PUFA. The study population was a sub-sample of adult participants in a randomised controlled trial of
b-carotene and sunscreen in the prevention of skin cancer (n 43). Dietary intake was assessed by a self-administered FFQ and a weighed food
record (WFR). Non-fasting blood samples were collected and analysed for plasma phospholipid fatty acids. Median intakes on the FFQ were gen-
erally higher than the WFR except for the n-3 PUFA groups, where the FFQ estimated higher intakes. Correlations between the FFQ and WFR
were moderate (r 0·32–0·59) except for trans fatty acids (r 0·03). Correlations between each of the dietary assessment methods and the plasma
phospholipids were poor for all fatty acids other than the PUFA. Using the methods of triads approach, the FFQ validity coefficients for total n-3
fatty acids, total long chain n-3 fatty acids, EPA, arachidonic acid, docosapentaenoic acid and DHA were 0·50, 0·63, 0·45 and 0·62 and 0·62,
respectively. For most fatty acids, the FFQ adequately estimates group mean fatty acid intakes and can adequately rank individuals; however,
the ability of this FFQ to estimate trans fatty acids was poor.
Validation: Fatty acids: Biomarkers: Dietary intake: FFQ: Weighed food record
Current dietary recommendations focus not only on the total
fat intake but on the types of fat consumed, in recognition
of the importance on differing roles of specific fatty acids in
health and disease. Increased n-3 intake has been suggested
as protective against chronic disease, particularly CVD; how-
ever, there is currently ongoing debate about their role in
health and further work is required to clarify this (Geleijnse
et al. 2006; He & Song, 2006; Hooper et al. 2006). Trans
fatty acids have been associated with the promotion of IHD
(Stender & Dyerberg, 2004). Measurement of dietary intake
of specific fatty acids or classes of fatty acids is increasingly
important.
While the difficulties associated with the measurement of
diet are well recognised, there are a number of issues specific
to the measurement of fatty acids. The increasing complexity
of the food supply and the availability of a wide range of man-
ufactured and processed foods, coupled with variations in the
fats and oils used by the food industry, makes characterisation
of the fatty acid composition of foods more difficult (Cant-
well, 2000; McNaughton et al. 2004).
Biomarkers of fatty acid status, such as plasma fatty acids,
have a number of characteristics useful in the validation of
dietary assessment methods. They are often considered objec-
tive, as they cannot be altered by the subject and do not rely
on a subject’s ability to recall intake or on compliance with
recording consumption (Kaaks et al. 1997). In addition, they
are not susceptible to the same type of measurement errors
as other dietary assessment methods, such as errors associated
with estimation of portion size or with the use of food compo-
sition databases (Gibson, 1990; Neuhoser et al. 2001). How-
ever, biomarkers are often not perfectly correlated with
dietary intake due to the presence of other determinants,
including factors related to metabolism or environmental and
lifestyle factors (Hunter, 1998).
Biomarkers of dietary fat intake have been more difficult to
identify than for the other nutrients. The ideal biomarker of
dietary fat intake would be able to reflect both quantity and
quality but currently no marker of total fat intake exists
(Arab, 2003). Measurement of individual fatty acids in
plasma may be used as biomarkers of fatty acid intake
(Ashley, 1996). PUFA have been shown to be the most
useful as biomarkers of dietary intake (Arab, 2003). Potential
non-dietary determinants of plasma lipids include sex, alcohol
and smoking (Simon et al. 1996; Bates et al. 1997).
The objective of this study was to evaluate the ability of
the Nambour FFQ to estimate intakes of specific fatty
acids, particularly PUFA, using plasma phospholipid
measurements and weighed food records (WFR). The validity
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of the questionnaire with regard to estimates of energy, macro-
nutrients and a range of micronutrients has previously been
investigated and published separately (Marks et al. 2006b).
Methods
A dietary intake validation study was conducted in a randomly
selected subset of participants of the Nambour Skin Cancer
Study (Ashton et al. 1996; Green et al. 1999; Marks et al.
2006a,b). Only subjects who had already completed the FFQ
at baseline in 1992 were eligible for selection. A total of
168 subjects were invited into the study, with 115 subjects
agreeing to participate and complete a FFQ and a WFR, repre-
senting a response rate of 68·5%.
Demographic variables and health-related behaviours were
collected via standardised interviews conducted by trained
nurses or self-administered questionnaires (Green et al.
1988). Anthropometric measurements (height and weight)
were made during a physical examination coinciding with
the administration of the FFQ using standardised protocols
(Gordon et al. 1988).
FFQ
Dietary intake was assessed in 1992 by a self-administered,
semi-quantitative FFQ based on a questionnaire designed for
use in the USA (Willett et al. 1985) and adapted for use in
Queensland. The questionnaire consisted of 129 items of
specific foods or food groups with nine response options ran-
ging from ‘never’ to ‘4 þ times per d’ for the frequency of
consumption of the specified serving sizes based on household
measures (e.g. cups, spoons) and natural units (e.g. 1 slice
bread). Among the list of foods specified were low, reduced
and full fat dairy products and lean meats v. fatty or processed
meats. Additional questions on the FFQ collected information
on the trimming of visible fat from meat, frequency of fried
food at home and fried takeaway food and specific types of
fats and oils used on bread, vegetables and in cooking. Ques-
tions on the use of self-prescribed nutritional supplements
were also included.
Subjects were asked to recall their frequency of consump-
tion of food items over the preceding 6 months. Average
daily intake was calculated by expressing the response to
the food item as a proportion of daily use, which was then
multiplied by the amounts (g) of the specified portion sizes
and by the nutrient content of the food. Seasonal foods were
weighted according to the proportion of the year that each
food was available. Subjects were excluded from analysis if
they responded to less than 90% of items on the FFQ.
Weighed food records
Subjects completed records on two non-consecutive days,
every 2 months for 12 months (during 1993). Starting days
were randomly allocated in the initial recording period and
then the rest of the week worked through in subsequent
recording periods so that weekdays, weekend days and sea-
sons were appropriately weighted over the year. Detailed
instructions on the use of the scales and the weighing and
recording of food and drink consumed and leftovers were pro-
vided for the participants during the initial interview.
Participants were asked to record information on time
and place of food and meal preparation, brand names of
products and recipes used. For meals eaten away from
home, participants were asked to provide detailed descriptions
and approximate amounts of what was eaten. Details of any
self-prescribed nutritional supplements consumed were also
recorded. Data from the WFR were entered into nutritional
computer software (Xyris Software, 1991; Xyris Software
(Australia) Pty Ltd, Highgate Hill, Queensland, Australia)
and the nutrient intakes were then downloaded for subsequent
processing and analyses. Subjects were excluded from analysis
if they had completed less than 10 d recording in the WFR.
Plasma phospholipid fatty acids
A randomly selected subset of subjects had blood samples
taken and analysed for plasma phospholipid fatty acids
(n 44). Prior to blood collection, respondents were requested
to eat a light breakfast (e.g. cereal, fruit, juice or coffee).
Non-fasting venous blood samples of 30ml were collected
using standard venipuncture techniques performed by experi-
enced phlebotomists. Blood samples were processed at the
time of collection and serum samples were stored in approxi-
mately 1ml aliquots at 2708C until analysis.
Measurements of plasma phospholipid fatty acids were con-
ducted by Flinders Medical Centre, Adelaide, Australia and are
described in detail in Mantzioris et al. (2000). Briefly, plasma
was extracted in chloroform:methanol and stored at 270 8C
before fatty acid analysis. The total lipid extract from the
plasma fractions was fractionated by TLC and the phospholipid
fractions retained. Fatty acid methyl esters were separated
and quantified with gas chromatograph (Hewlett-Packard
6890 with a 50-m capillary column; Hewlett-Packard, Palo
Alto, CA, USA). Fatty acid methyl esters were identified
based on the retention time to authentic lipid standards
(GLC-463; Nuchek Prep Inc. Elysian, MN, USA) and quantified
by comparison with the peak area of the internal standard
using ChemStation software (Agilent, Palo Alto, CA, USA).
Data analysis
All analysis in the present study is based on subjects who had
completed all three assessments (FFQ, WFR and biomarker;
n 44). Fatty acid intakes from the WFR and the FFQ were cal-
culated using a comprehensive fatty acid database for Austra-
lian foods (Mann et al. 2003). Energy intakes were assessed to
identify subjects with extreme and implausible energy intakes
(.16 800 kJ/d and ,3360 kJ/d for males and .14 700 kJ/d
and ,2100 kJ/d for females; Willett, 1998). One person was
excluded on this basis. Fatty acid intakes on the WFR and
FFQ represent intakes from food alone (only one subject
reported using supplements containing fish oils). Intakes of
fatty acids were adjusted for energy intake using the nutrient
residual method as recommended in validation studies (Will-
ett, 1998, 2001). Mean intakes on the WFR and FFQ were
compared using Student’s t tests. Agreement between the
FFQ and the WFR was also assessed. The proportions of indi-
viduals classified in the same third of the distribution (exact
agreement) and into extreme thirds of the distribution (gross
misclassification) were calculated. Spearman correlation
coefficients were calculated between each of the three dietary
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assessment methods (i.e. FFQ and WFR; FFQ and biomarker;
WFR and biomarker) for each fatty acid. Correlations were
evaluated as poor (,0·2), moderate (0·2–0·6) or good
(.0·6). For the PUFA, the correlations between each of the
three dietary exposure methods were used to calculate the val-
idity coefficient via the method of triads (Ocke & Kaaks,
1997). The triangular approach to validation assumes that
the correlations between the three measurements are explained
by the fact that they are all linearly correlated with the true
intake. The method of triads provides an upper limit of the
validity coefficient while the correlations between the ques-
tionnaire measurement and the biomarker measurement pro-
vide an estimate of the lower limit of the validity coefficient
(Ocke & Kaaks, 1997; McNaughton et al. 2005). The 95%
CI for the validity coefficients were estimated using bootstrap
sampling where 1000 samples of equal size (n 43) were
obtained with replacement from the study subjects. Analyses
were performed using SPSS for Windows Version 10.0.5
(SPSS Inc., Chicago, IL, USA). P values ,0·05 were con-
sidered significant.
Results
Table 1 provides details on the general characteristics for
study subjects including age, BMI, smoking status and sup-
plement use. Table 2 presents the mean, standard deviation
and median of the dietary intakes of selected fatty acids as
measured on the WFR and FFQ and the plasma phospholipid
fatty acids. Totals represent the sum of all fatty acids detected
in plasma and in foods consumed (not just those listed separ-
ately). In general, median intakes on the WFR were higher
than the FFQ (up to 1·13-fold higher) except for the n-3
PUFA groups, where the FFQ estimated higher intakes (up
to 1·40-fold higher). However, mean intakes were not signifi-
cantly different between the WFR and FFQ for most of the
fatty acids except for total trans fatty acids, with the FFQ pro-
viding higher estimates than the WFR. Exact agreement
ranged from 30% (trans fatty acids) to 56% (oleic acid).
Gross misclassification ranged from 2% (stearic acid) to
23% (trans fatty acids).
The Spearman correlation coefficients between each of the
three dietary assessment methods are shown in Table 3. The
correlations between the FFQ and WFR ranged from 0·32
(linoleic acid and total n-6 fatty acids) to 0·59 (total SFA)
except for trans fatty acids (r 0·03). Correlations between
each of the dietary assessment methods and the plasma phos-
pholipids were less than 0·20 for all fatty acids other than the
PUFA.
With regard to the PUFA, correlations between the WFR
and plasma phospholipids ranged from 0·22 to 0·44 for total
n-3 fatty acids, total long chain fatty acids, arachidonic acid,
EPA, docosapentaenoic acid and DHA. Correlations between
the FFQ and plasma phospholipids ranged from 0·21 to 0·38
for total n-3 fatty acids, total long chain fatty acids, linoleic
acid, EPA and DHA. Correlations tended to be stronger
between the plasma fatty acids and WFR than the FFQ. Cor-
relations between the plasma phospholipids and both the WFR
and FFQ for a-linolenic were less than 0·09 while the corre-
lations for plasma phospholipid linoleic acid and total n-6
fatty acids showed large variations between the WFR and
FFQ. The correlations between the plasma phospholipids
and the FFQ and WFR were also calculated when subjects
using dietary supplements containing fish oils were excluded
(one subject) and results were similar (data not shown).
Adjustments for sex, alcohol and smoking did not consistently
alter the correlations.
The correlations between each of the three dietary exposure
measurements for PUFA were used to calculate the validity
coefficient for each of the methods using the method of
triads approach along with the 95% CI calculated by the boot-
strap method (Table 4). The range for the validity coefficient
is also presented, where the upper limit is that calculated by
the method of triads and the lower limit is the correlation
between the FFQ and the biomarker. However, when using
the method of triads, a validity coefficient cannot be calculated
if one of the three correlations is negative (Ocke & Kaaks,
Table 1. Characteristics of the validation study participants*
(Mean values, standard deviations and range for forty-three participants)
Females (n 25) Males (n 18)
Mean SD Range Mean SD Range
Age (years) 49·5 10·2 28–75 53·8 12·7 29–72
BMI (kg/m2) 26·3 4·0 19·6–33·7 24·5 3·6 20·0–31·1
n % n %
Smoking
Non-smoker 13 54·2 9 50·0
Current smoker 0 2 11·1
Ex-smoker 11 45·8 5 27·8
Missing 1 4·0 2 11·1
Supplement use†
Any 11 44 5 28
Containing fish oils 1 1 1 1
* Characteristics of the participants of the Nambour Skin Cancer Study (n 1621) are: 43·7 % male; age 49·51
(SD 13·19) years; BMI: 26·16 (SD 4·32) kg/m2; 48·7 % non-smokers and 37·3 % supplement users.
† Includes supplements containing vitamins, minerals or herbal ingredients and is based on data collected as
part of the FFQ.
For details of subjects and procedures, see p. 562.
FFQ estimates of fatty acid intake 563
https://doi.org/10.1017/S0007114507381385
Downloaded from https:/www.cambridge.org/core. UQ Library, on 03 Feb 2017 at 02:19:26, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
Table 2. Plasma phospholipids fatty acids and dietary fatty acid intakes as estimated by weighed food records (WFR) and FFQ†
(Mean values, standard deviations and median values for forty-three participants)
Plasma (mg/ml) FFQ (g) WFR (g) Agreement‡
Mean SD Median Mean SD Median Mean SD Median Exact (%) GM (%)
Saturated Total 605·56 127·85 569·12 30·33 12·55 27·22 29·43 9·41 29·56 51 7
Palmitic (16 : 0) 362·96 82·93 346·07 15·22 5·86 13·35 14·66 4·51 14·36 40 5
Stearic (18 : 0) 201·35 46·77 196·28 7·31 3·11 6·62 6·95 2·29 7·02 51 2
Monounsaturated Total 177·52 50·81 162·82 25·40 8·91 22·50 23·40 7·03 23·65 51 12
Oleic (18 : 1n-9) 134·56 41·47 126·97 23·39 8·32 21·01 21·66 6·56 22·10 56 12
Trans Total 13·65 3·98 13·58 0·11 0·31 0·01 0·01 0·01 0·01* 30 23
Polyunsaturated Total n-6 506·06 102·64 489·37 8·47 2·93 7·84 9·38 3·78 8·86 51 12
Total n-3 79·92 21·71 78·13 1·12 0·50 1·01 1·02 0·37 0·98 44 14
Total long chain n-3§ 77·25 21·25 73·95 0·26 0·21 0·20 0·22 0·26 0·16 42 12
Linoleic (18 : 2n-6) 286·47 62·88 271·4 8·37 2·92 7·69 9·28 3·76 8·72 51 12
Arachidonic acid (20 : 4n-6) 144·85 41·59 137·62 0·08 0·03 0·08 0·09 0·04 0·08 51 7
a-Linolenic acid (18 : 3n-3) 1·66 0·85 1·33 0·86 0·42 0·76 0·80 0·23 0·80 49 9
EPA (20 : 5n-3) 11·46 7·49 9·39 0·09 0·08 0·07 0·08 0·11 0·05 42 12
DPA (22 : 5n-3) 15·13 4·22 14·63 0·04 0·02 0·03 0·04 0·03 0·03 42 7
DHA (22 : 6n-3) 50·67 15·49 48·85 0·12 0·12 0·09 0·11 0·13 0·08 51 7
Significantly different mean intakes on the FFQ and WFR (*P,0·05; two-sided t test). Intakes were log-transformed prior to analysis.
† Energy intakes (kJ) were as follows: FFQ 9969 (SD 2851), median 9598; WFR, 8346 (SD 2246), median 7903.
‡ Agreement between the WFR and FFQ. Exact refers to exact agreement between thirds of the distribution. GM refers to misclassification into thirds of the distribution.
§ Includes EPA, docosapentaenoic acid (DPA) and DHA (Meyer et al. 2003).
For details of subjects and procedures, see p. 562.
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1997); therefore, the validity coefficient could not be
calculated for total n-6 fatty acids, linoleic acid, a-linolenic
acid and docosapentaenoic acid. Validity coefficients for the
FFQ ranged from 0·45 (arachidonic acid) to 0·63 (total long
chain n-3 fatty acids). Validity coefficients for the WFR
tended to be the highest, followed by the validity coefficients
of the FFQ, with those of the plasma biomarkers tending to be
the lowest.
Discussion
The objective of the present study was to evaluate the ability
of the Nambour FFQ to estimate intakes of specific fatty acids.
When compared with a WFR, mean intakes of individual and
specific classes of fatty acids were not significantly different,
except for the trans fatty acid intake, where the FFQ provided
higher estimates of intake. Correlations between the WFR and
FFQ were moderate to good, indicating that the FFQ could
adequately rank subjects for most fatty acids. Percentage
agreement between the FFQ and WFR showed similar patterns
to the correlation analysis, with trans fatty acids showing poor
agreement. The magnitude of the correlations between WFR
and FFQ in the current study is similar to that seen in other
validation studies (Riboli et al. 1997; Brunner et al. 2001)
and consistent with previously published results in the larger
validity study (Marks et al. 2006b).
Diet-plasma correlations were moderate for total n-3 fatty
acids, total long chain fatty acids, linoleic acid, EPA and
DHA for both the WFR and the FFQ, although those with
the WFR were generally higher. Both methods showed poor
correlations for a-linolenic acid. As expected due to the
capacity for endogenous synthesis of SFA and MUFA, diet-
plasma correlations were poor for SFA and MUFA. The pre-
sent results are similar to findings of other studies showing
moderate to good correlations for EPA, DHA, linoleic acid
(r 0·3–0·7) and also for all PUFA combined (r 0·3–0·5;
Von Houwelingen et al. 1989; Bonaa et al. 1992; Moilanen
et al. 1992; James et al. 1993; Ma et al. 1995; Stallone et al.
1997). Weaker correlations have been shown for SFA and
generally poor correlations have been observed for MUFA
Table 3. Spearman correlation coefficients between each of the three dietary assessment methods (n 43)†
FFQ v. WFR WFR v. Biomarker FFQ v. Biomarker
Saturated Total 0·59* 20·09 20·04
Palmitic (16 : 0) 0·46* 20·10 20·09
Stearic (18 : 0) 0·53* 0·02 20·02
Monounsaturated Total 0·48* 20·13 20·10
Oleic (18 : 1n-9) 0·47* 20·11 20·06
Trans Total 0·03 0·16 0·19
Polyunsaturated Total n-6 0·32* 20·11 0·16
Total n-3 0·39* 0·33* 0·21
Total long chain n-3 0·46* 0·44* 0·38*
Linoleic acid (18 : 2n-6) 0·32* 20·01 0·34*
Arachidonic acid (20 : 4n-6) 0·54* 0·35* 0·13
a-linolenic acid (18 : 3n-3) 0·45* 0·09 0·00
EPA (20 : 5n-3) 0·40* 0·22 0·21
DPA (22 : 5n-3) 0·50* 0·25 20·05
DHA (22 : 6n-3) 0·52* 0·43* 0·32*
Significant correlations (*P,0·05).
† Fatty acid intakes from the weighed food records (WFR) and FFQ were adjusted for energy intake.
DPA, docosapentaenoic acid.
For details of subjects and procedures, see p. 562.
Table 4. Validity coefficient of the FFQ, weighed food records (WFR) and biomarkers for PUFA as calculated by the method of triads and the 95 % CI
(n 43)*
Validity coefficients† Range of the validity coefficients‡
rQT 95 % CI rBT 95 % CI rRT 95 % CI rQT rBT rRT
Total n-3 0·50 0·13, 1·00 0·43 0·10, 0·81 0·78 0·29, 1·00 0·21–0·50 0·33–0·43 0·21–0·78
Total long chain n-3 0·63 0·27, 0·98 0·60 0·27, 0·93 0·73 0·34, 1·00 0·38–0·63 0·44–0·60 0·38–0·73
Arachidonic acid (20 : 4n-6) 0·45 0·13, 1·00 0·29 0·06, 0·69 1·00 0·43, 1·00 0·13–0·45 0·35–0·29 0·13–1·00
EPA (20 : 5n-3) 0·62 0·18, 1·00 0·35 0·07, 0·78 0·65 0·18, 1·00 0·21–0·62 0·22–0·35 0·21–0·65
DHA (22 : 6n-3) 0·62 0·25, 0·91 0·52 0·16, 0·82 0·83 0·45, 1·00 0·32–0·62 0·43–0·52 0·32–0·83
* The validity coefficient could not be calculated for total n-6 fatty acids, linoleic acid, a-linolenic acid and docosapentaenoic acid as one of the three correlations was negative
or zero.
† All values .1·00 were truncated as this is the highest possible value.
‡ The lower limit for the FFQ and the biomarker is the correlation between the FFQ and biomarker, and the lower limit for the WFR is the correlation between the biomarker
and the WFR, and the upper limit is calculated by the method of triads.
rQT, validity coefficient of the questionnaire; rBT, validity coefficient of the biomarker; rRT, validity coefficient of the WFR.
For details of subjects and procedures, see p. 562.
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(Moilanen et al. 1992; Ma et al. 1995). Correlations for EPA in
the current study were lower than expected when considering
the results of previous studies, which have shown equally
strong correlations between diet and plasma for DHA and
EPA. Correlations between the WFR and biomarker for ara-
chidonic acid were greater than expected given that its metab-
olism is well regulated (Arab, 2003) and given that Baylin
et al. (2005) showed poor correlations (r 0·05–0·12) between
dietary arachidonic acid measured by FFQ and three bio-
markers; results that are consistent with our FFQ results.
Kabagambe et al. (2001) used the method of triads approach
with adipose tissue fatty acid biomarkers and multiple 24-h
dietary recalls and estimated the validity coefficients for a
FFQ of 0·59 and 0·89 for a-linolenic acid and linoleic acid,
respectively. We were not able to estimate validity coefficients
for these fatty acids due to negative correlations, so compari-
sons are not possible.
It is important to note the different reference periods or time
frames for each of the dietary exposure measures in the pre-
sent study. The FFQ was administered in 1992 and asked
respondents to consider intake over the previous 6 months.
The biomarker measurements were made at approximately
the same time and are likely to represent the preceding days
to weeks of dietary exposure. In contrast, the WFR were com-
pleted approximately 1 year later. The correlations observed
may be an underestimate of the true correlations due to the
differing time frames.
The use of biomarkers of fatty acid intake is advantageous
due to the specific difficulties associated with quantifying the
intakes of individual fatty acids and classes of fatty acids. The
FFQ included questions relating to trimming of visible fat
from meat, frequency of fried food consumption and specific
types of fats and oils used, including brand level information
for fat spreads and oils, and this information was used in the
calculation of fatty acid intakes. Regardless of the level of
detail obtained from the subjects, all assessments of nutrient
intake are limited by the available food composition database.
The availability of a wide range of manufactured and pro-
cessed foods, coupled with variations in the fats and oils
used by the food industry, increases the difficulties associated
with the estimation of the fatty acid composition of foods
and subsequent estimation of intakes (Mishra et al. 2003;
McNaughton et al. 2004). The difficulties associated with
incomplete food composition databases have recently been
highlighted (McNeill et al. 2004). However, the present
study used the most complete fatty acid food composition
database currently available for the Australian food supply
(Mann et al. 2003).
The current study showed poor correlations for the trans
fatty acids. There was a significant decrease in the trans
fatty acid content of the food supply in Australia in early
1996 due to the removal of trans fatty acids from many mar-
garines (Clifton et al. 2004). The present study drew on food
composition data that would have included data pre and post
the decrease in trans fatty acids and we attempted to use the
most appropriate data for each food item consumed in the
study. The poor correlations observed suggest that this may
be a source of error in our estimates of trans fatty acid
intake. The poor correlations between a-linolenic acid intakes
and plasma phospholipid concentrations may have also been
affected by errors associated with the food composition data,
particularly around trans fatty acids, due to the concurrent
changes in PUFA that occur with production of trans fatty
acids during partial hydrogenation of vegetables oils
(Ascherio & Willett, 1997).
A variety of factors may affect plasma lipids independent of
dietary intake. Smoking and alcohol have been shown to be
associated with the concentrations of various fatty acids inde-
pendently of dietary fat, energy, cholesterol and BMI in pre-
vious studies, which suggested that smoking and alcohol
intake may impact on the absorption, synthesis or metabolism
of fatty acids (Simon et al. 1996). In the current study, alcohol
and smoking were not associated with plasma fatty acid levels
(data not shown) and adjustment of the diet-plasma corre-
lations for alcohol and smoking had no consistent effects.
Previous work in this study population (Marks et al.
2006a,b) has shown that the validity of the FFQ varies accord-
ing to a number of personal factors or subject characteristics.
For example, with regard to fat intakes, age, BMI, sex and pre-
sence of a medical condition were shown to be independent
predictors of the difference in intakes on the FFQ and WFR.
These factors will presumably act in a similar way with
regard to individual fatty acids; however, the small sample
size of the current study precluded their investigation. There-
fore, analyses of diet–disease relationships investigating indi-
vidual fatty acid intakes would require adjustment for these
factors as previously suggested for the major fat sub-groups
(Marks et al. 2006b).
The method of triads has been applied in a small number of
dietary validation studies and is used to determine the validity
coefficient of a questionnaire measure of intake using two
additional measures, such as WFR and biomarkers (Kaaks
et al. 1997; Ocke & Kaaks, 1997; Kabagambe et al. 2001;
Fowke et al. 2002; Pufulete et al. 2002; Bhakta et al. 2005;
Brevik et al. 2005; Shai et al. 2005). The triangular approach
to validation uses the correlations between each of the three
methods to calculate the validity coefficient. It assumes that
the correlations between the three measurements are explained
by the fact that they are all linearly correlated with the true
intake and assumes that errors associated with each of the
methods are not correlated. As the FFQ and WFR may have
some common sources of error (e.g. food composition data-
base values) and therefore their errors may be correlated, so
the validity coefficient provided by the method of triads
should be considered an upper limit. A lower limit for the val-
idity coefficient is provided by the correlations between the
questionnaire measurement and the biomarker measurement.
The method of triads approach does have some limitations,
for example, the occurrence of values .1, known as Heywood
cases, which may result from either random sampling vari-
ations or violations to the model assumptions (Ocke &
Kaaks, 1997; Daures et al. 2000). Also, its use is restricted
to situations in which a biomarker that is known to reflect to
diet is available (Shai et al. 2005). Hence, the use of the
method of triads was restricted in the present study to
measures of PUFA intake.
Reproducibility and validity studies are generally conducted
in a sub-sample of a population being investigated as part of a
larger epidemiological investigation. Differences between the
sample used for the validity study and the overall study popu-
lation with regard to education level, sex and age may influence
the validity of the dietary assessment tool (Armstrong et al.
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1992). Similarly, differences in the distribution of the dietary
exposure between the validity study group and the overall
study group may affect the validity of the method (Armstrong
et al. 1992). In addition, subjects who participate in dietary vali-
dation studies may be different from the general population due
to their willingness to participate and compliancewith recording
dietary intake and this may result in overestimation of the val-
idity of the FFQ (Armstrong et al. 1992). Subjects who partici-
pated in the current validation study and had dietary exposure
data available from all three sources were similar to the overall
Nambour Skin Cancer Study group with regard to a number of
factors, including age, BMI, smoking status and the proportion
of males and females present (Green et al. 1999). With regard
to dietary and plasma fatty acids, intakes of fatty acids in this
sample were comparable with intakes of the general Australian
population based on the 1995 Australian National Nutrition
Survey, an analysis using the same food composition database
(Meyer et al. 2003) and plasma phospholipid concentrations
were also similar to other studies of Australian adults (Man-
tzioris et al. 2000; Woods et al. 2002).
The present study evaluated the ability of the Nambour Skin
Cancer Study FFQ to estimate PUFA intakes. Using methods
of triads approach we determined that validity coefficients for
the FFQ were greater than 0·40 for the PUFA. For SFA and
MUFA, comparisons of the FFQ and the WFR suggest that
the FFQ adequately estimates group mean fatty acid intakes
and can adequately rank individuals. However, trans fatty
acids were poorly estimated by this particular FFQ.
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